Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease
-
- Anthony J. Donato
- From the Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City; and Veterans Affairs Medical Center, Geriatrics Research Education and Clinical Center, Salt Lake City, UT.
-
- Daniel R. Machin
- From the Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City; and Veterans Affairs Medical Center, Geriatrics Research Education and Clinical Center, Salt Lake City, UT.
-
- Lisa A. Lesniewski
- From the Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City; and Veterans Affairs Medical Center, Geriatrics Research Education and Clinical Center, Salt Lake City, UT.
説明
<jats:p> Advancing age promotes cardiovascular disease (CVD), the leading cause of death in the United States and many developed nations. Two major age-related arterial phenotypes, large elastic artery stiffening and endothelial dysfunction, are independent predictors of future CVD diagnosis and likely are responsible for the development of CVD in older adults. Not limited to traditional CVD, these age-related changes in the vasculature also contribute to other age-related diseases that influence mammalian health span and potential life span. This review explores mechanisms that influence age-related large elastic artery stiffening and endothelial dysfunction at the tissue level via inflammation and oxidative stress and at the cellular level via <jats:italic>Klotho</jats:italic> and energy-sensing pathways (AMPK [AMP-activated protein kinase], SIRT [sirtuins], and mTOR [mammalian target of rapamycin]). We also discuss how long-term calorie restriction—a health span- and life span-extending intervention—can prevent many of these age-related vascular phenotypes through the prevention of deleterious alterations in these mechanisms. Lastly, we discuss emerging novel mechanisms of vascular aging, including senescence and genomic instability within cells of the vasculature. As the population of older adults steadily expands, elucidating the cellular and molecular mechanisms of vascular dysfunction with age is critical to better direct appropriate and measured strategies that use pharmacological and lifestyle interventions to reduce risk of CVD within this population. </jats:p>
収録刊行物
-
- Circulation Research
-
Circulation Research 123 (7), 825-848, 2018-09-14
Ovid Technologies (Wolters Kluwer Health)